CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Amneal Pharmaceuticals LLC v. Teva Pharmaceuticals USA, Inc.

1:17-cv-00074

Overview

Case Number 1:17-cv-00074
Filing Date 2017-01-25
Status Terminated
Termination Date 2018-01-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand None

Parties

Defendant

Teva Neuroscience, Inc. Operating Company

Represented By

2 Attorneys Listed

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Teva Pharmaceutical Industries, Ltd. Operating Company

Represented By

2 Attorneys Listed

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

9 Attorneys Listed

William G. James

Email: william.james@allenovery.com

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John T. Bennett

Email: jbennett@goodwinlaw.com

Elizabeth J. Holland

Email: Elizabeth.Holland@allenovery.com

David M. Hashmall

Email: dhashmall@goodwinlaw.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Brian T. Drummond

Email: BDrummond@goodwinlaw.com

Plaintiff

Amneal Pharmaceuticals Company GmbH Operating Company

Represented By

1 Attorneys Listed

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Amneal Pharmaceuticals LLC Operating Company

Represented By

5 Attorneys Listed

Patrick C. Gallagher

Email: pcgallagher@duanemorris.com

Christopher S. Kroon

Email: CSKroon@duanemorris.com

Carolyn A. Alenci

Email: caalenci@duanemorris.com

Anthony J. Fitzpatrick

Email: AJFitzpatrick@duanemorris.com

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇨🇦 Canada CN 🇪🇺 Europe 🇯🇵 Japan KR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9155775
Process for manufacturing glatiramer acetate product
Filed: 2015-01-28
Issued: 2015-10-13
Active (8.2 yrs remaining)
Expires: 2035-01-28
US9155755
Dietary supplements including glucan and fulvic acid
Filed: 2014-03-12
Issued: 2015-10-13
Active (7.3 yrs remaining)
Expires: 2034-03-12

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

23

Dispositive

12

Granted

0

Denied

0

Pending / Review

19

Motions by Category

Procedural / Extension Motion 8 Motion to Transfer Venue (28 U.S.C. § 1404) 12 Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
STIPULATION Stipulation to Withdraw Pending Venue Related Motions re 22 MOTION to Transfer Case to Eastern District of New York, 13 MOTION to Enjoin Defendants ...
Entry #46 • 2017-07-07 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
Letter to Judge Sleet from Richard L,. Renck (Counsel for Amneal Plaintiffs) writing on behalf of Amneal Plaintiffs and Teva Defendants regarding Agreement by t...
Entry #47 • 2017-07-07 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending
Order on Motion for Enjoin AND Order on Motion to Transfer Case
Entry #— • 2017-07-07
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
Letter to The Honorable Gregory M. Sleet from Richard L. Renck, Esq., Counsel for Plaintiffs regarding Regarding transfer decision - re 22 MOTION to Transfer Ca...
Entry #36 • 2017-04-05 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
REPLY BRIEF re 22 MOTION to Transfer Case to Eastern District of New York filed by Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceu...
Entry #35 • 2017-03-28 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
BRIEF (Combined Memorandum in Opposition to Defendants' Motion to Transfer Venue to the Eastern District of New York and Reply Memorandum in Support of their Mo...
Entry #33 • 2017-03-21 Document →

Docket Entries

(90 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT filed against Teva Neuroscience, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2072461.) - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(lmm) (Entered: 01/26/2017)

Entry #1 • 2017-01-25
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) (Entered: 01/26/2017)

Entry #2 • 2017-01-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,155,775 BI. (lmm) (Entered: 01/26/2017)

Entry #3 • 2017-01-25
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holding Company, LLC, Corporate Parent Amneal Holdings, LLC for Amneal Pharmaceuticals LLC; Corporate Parent Amneal Pharmaceuticals Holdings, GmbH for Amneal Pharmaceuticals Company GmbH filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC. (lmm) (Entered: 01/26/2017)

Entry #4 • 2017-01-25
1
Pleading / Complaint

SUMMONS Returned Executed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH. Teva Pharmaceuticals USA, Inc. served on 1/26/2017, answer due 2/16/2017. (Renck, Richard) (Entered: 01/26/2017)

Entry #5 • 2017-01-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc